Sai Parenteral's Stellar Market Debut: Shares Surge Beyond Expectations
Sai Parenteral, a pharmaceutical company, saw its shares rise nearly 4% above the issue price on debut. With a fresh issue of Rs 285 crore and strong institutional backing, the IPO aims to bolster the firm's global business, particularly in formulations and manufacturing. Market valuation reached Rs 1,795.44 crore.
- Country:
- India
Sai Parenteral's shares delivered a notable performance on their debut, concluding nearly 4% above the issue price of Rs 392 on the stock exchange.
The pharmaceutical company's shares opened trading at Rs 405 on the BSE, rising 3.32% initially and peaking at Rs 416.20, before settling at Rs 406.40.
The IPO aims to raise Rs 285 crore for expanding its global formulations business, buoyed by a 1.05 times subscription rate and strong institutional interest.
Google News